Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 223

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Serum neurofilament light: A biomarker of neuroaxonal injury after ischemic stroke

Open access
Tiedt, Steffen, Duering, Marco, Barro, Christian, Kaya, Asli Gizem, Boeck, Julia, Bode, Felix J., Klein, Matthias, Dorn, Franziska, Gesierich, Benno, Kellert, Lars, Ertl-Wagner, Birgit, Goertler, Michael W., Petzold, Gabor C., Kuhle, Jens, Wollenweber, Frank A., Peters, Nils, Dichgans, Martin · 2018 · Neurology

Abstract

Objective To explore the utility of serum neurofilament light chain (NfL) as a biomarker for primary and secondary neuroaxonal injury after ischemic stroke (IS) and study its value for the prediction of clinical outcome. Methods We used an ultrasensitive single-molecule array assay to measure serum NfL levels in healthy controls (n = 30) and 2 independent cohorts of patients with IS: (1) with serial serum sampling at hospital arrival (n = 196), at days 2, 3, and 7 (n = 89), and up to 6 months post stroke; and (2) with standardized MRI at baseline and at 6 months post stroke, and with cross-sectional serum sampling at 6 months (n = 95). We determined the temporal profile of serum NfL levels, their association with imaging markers of neuroaxonal injury, and with clinical outcome. Results Patients with IS had higher serum NfL levels compared with healthy controls starting from admission until 6 months post stroke. Serum NfL levels peaked at day 7 (211.2 pg/mL [104.7–442.6], median [IQR]) and correlated with infarct volumes (day 7: partial r = 0.736, p = 1.5 × 10−15). Six months post stroke, patients with recurrent ischemic lesions on MRI (n = 19) had higher serum NfL levels compared to those without new lesions (n = 76, p = 0.002). Serum NfL levels 6 months post stroke further correlated with a quantitative measure of secondary neurodegeneration obtained from diffusion tensor imaging MRI (r = 0.361, p = 0.001). Serum NfL levels 7 days post stroke independently predicted modified Rankin Scale scores 3 months post stroke (cumulative odds ratio [95% confidence interval] = 2.35 [1.60–3.45]; p = 1.24 × 10−05). Conclusion Serum NfL holds promise as a biomarker for monitoring primary and secondary neuroaxonal injury after IS and for predicting functional outcome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000006282

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 223

Metadata

Authors
Tiedt, S., Duering, M., Barro, C., Kaya, A. G., Boeck, J., Bode, F. J., Klein, M., Dorn, F., Gesierich, B., Kellert, L., Ertl-Wagner, B., Goertler, M. W., Petzold, G. C., Kuhle, J., Wollenweber, F. A., Peters, N., & Dichgans, M.
Venue
Neurology
Published
2018-10-02
Volume
91
Issue
14
Pages
e1338-e1347
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2889825783
Cited by
223
References
10
FWCI
12.95
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum neurofilament light: A biomarker of neuroaxonal injury after ischemic stroke. https://app.cochat.ai/papers/10.1212/wnl.0000000000006282
The paper
Tiedt, S., Duering, M., Barro, C., Kaya, A. G., Boeck, J., Bode, F. J., Klein, M., Dorn, F., Gesierich, B., Kellert, L., Ertl-Wagner, B., Goertler, M. W., Petzold, G. C., Kuhle, J., Wollenweber, F. A., Peters, N., & Dichgans, M. (2018). Serum neurofilament light: A biomarker of neuroaxonal injury after ischemic stroke. Neurology. https://doi.org/10.1212/wnl.0000000000006282

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.